Pharmacokinetics and bioequivalence study of a generic desloratadine tablet formulation in healthy male volunteers

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 3, 2004, Pages 166-170

  Yeh, Geng Chang ^a   Deng, Shin Tarng ^b   Lo, Chin Yi ^c   Chiang, Pei Shan ^c,d   Hsiong, Cheng Huei ^e  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c New Business Development Department   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

CAS 100643 71 8; Denosin , bioequivalence, pharmacokinetics; Desloratadine, bioequivalence, pharmacokinetics

Indexed keywords

DENOSIN; DESLORATADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADULT; ALLERGY; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET FORMULATION; TANDEM MASS SPECTROMETRY;

EID: 1642353041     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296954     Document Type: Article

References (8)

1. Kreutner, W., Hey, J. A., Anthes, J. et al., Preclinical Pharmacology of Desloratadine, a Selective and Nonsedating Histamine H1 Receptor Antagonist: 1st Communication: Receptor Selectivity, Antihistaminic Activity, and Antiallergenic Effects. Arzneim.-Forsch./Drug Res. 50 (I), 345 (2000)
2. 1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis. Assessment During the Spring and Fall Allergy Seasons. Clin. Drug Invest. 21, 25 (2001)
3. Affrime, M., Banfield, C., Gupta, S. et al., Effect of Race and Sex on Single and Multiple Dose Pharmacokinetics of Desloratadine. Clin. Pharmacokinet. 41, 21 (2002)
4. Gupta, S., Banfield, C., Affrime, M. et al., Desloratadine Demonstrates Dose Proportionality in Healthy Adults After Single Doses. Clin. Pharmacokinet. 41, 1 (2002)
5. Gupta, S., Banfield, C., Affrime, M. et al., Oral Bioavailability of Desloratadine Is Unaffected by Food. Clin. Pharmacokinet. 41, 7 (2002)
6. Affrime, M., Gupta, S., Banfield, C. et al., A Pharmacokinetic Profile of Desloratadine in Healthy Adults, Including Elderly. Clin. Pharmacokinet. 41, 13 (2002)
7. Shargel, L., Yu, A. B. C., Applied Biopharmaceutics and Pharmacokinetics, 3rd ed., p. 353, Appleton & Lange, Stamford, CT (1991)
8. Chow, S. C., Liu, J. P., Design and Analysis Bioavailability and Bioequivalence Studies, p. 163, Marcel Dekker, New York (1992)